Literature DB >> 2642722

Popliteal aneurysms: an index of generalized vascular disease.

C W Cole1, A M Thijssen, G G Barber, N V McPhail, T K Scobie.   

Abstract

A review of 59 popliteal aneurysms in 38 patients seen over 10 years revealed that 34 (58%) aneurysms were symptomatic. Symptoms included gangrene (15%), ischemia due to thrombosis (38%) and embolism (5%). Patients with unilateral aneurysms (45%) were a median of 7 years younger than those with bilateral lesions (55%). The latter group had more frequent manifestations of occlusive disease, which included previous myocardial infarction, coronary artery bypass grafting and stroke. They also had more concomitant aneurysms, those of the abdominal aorta and femoral and iliac arteries being the most common. Management consisted of bypass grafting in 34 limbs and immediate amputation in 9; 16 inoperable limbs remained viable. At last follow-up (median 32 months) or time of death, 30 of 34 grafts were patent. Four grafts occluded, one perioperatively and the others at 4, 5, and 32 months respectively, resulting in two amputations. The cumulative patency rate in the asymptomatic group was 94% compared with 81% in the symptomatic group. These data illustrate that patients with popliteal aneurysms may have associated vascular disease, the likelihood of which is increased when aneurysms are bilateral.

Entities:  

Mesh:

Year:  1989        PMID: 2642722

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  2 in total

1.  Arteriomegaly with synchronous true aneurysms; Management of Common Femoral Artery and Profunda Femoris Artery aneurysms in a 70-year-old male - A case report.

Authors:  Okab Yahya; Mohammad Mohannad Obaisy; Omar Al Laham; Mohammad Ghannam; Ammar Mohammad
Journal:  Int J Surg Case Rep       Date:  2022-05-04

2.  The management of popliteal aneurysm: the importance of early surgical repair.

Authors:  A W Halliday; P R Taylor; J H Wolfe; A O Mansfield
Journal:  Ann R Coll Surg Engl       Date:  1991-07       Impact factor: 1.891

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.